Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?-Reference-Cited by-同舟云学术

Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?

Published:2017-08-29 Issue:1 Volume:23 Page:36-45
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Dheda Keertan¹^ORCID,Cox Helen²,Esmail Aliasgar¹,Wasserman Sean³,Chang Kwok Chiu⁴,Lange Christoph⁵

Affiliation:

1. Lung Infection and Immunity Unit, Department of Medicine, Division of Pulmonology and UCT Lung Institute; University of Cape Town; Cape Town South Africa

2. Division of Medical Microbiology, and the Institute of Infectious Disease and Molecular Medicine; University of Cape Town; Cape Town South Africa

3. Clinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, Department of Medicine; University of Cape Town; Cape Town South Africa

4. Department of Health, Tuberculosis and Chest Service; Centre for Health Protection; Hong Kong China

5. Division of Clinical Infectious Diseases, German Center for Infection Research (DZIF); Research Center Borstel; Borstel Germany

Funder

Wellcome Trust

South African MRC

South African NRF

European and Developing Countries Clinical Trials Partnership

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link